A Study Comparing an Investigational Wound Gel With Standard Treatment for Mild to Moderate Diabetic Foot Ulcers
This clinical trial is studying an investigational wound gel called VES-0-D for the treatment of mild to moderate diabetic foot ulcers. The trial aims to determine if this gel is more effective than standard wound care in promoting healing. The study is currently recruiting participants at several sites in Belgium, and it will compare wound area reduction over an 8-week treatment period. Participants will receive the gel or standard care every 3-4 days, visit the clinic weekly for assessments, and keep a diary of their symptoms. This research is important because diabetic foot ulcers are a serious complication of diabetes that can lead to infections and even amputation if not treated effectively. In China, diabetic foot ulcer management is a growing concern, and findings from this trial could inform future treatment options and best practices.
Key takeaways
- Tests a new wound gel (VES-0-D) versus standard care for diabetic foot ulcers.
- The trial is actively recruiting in Belgium, with sites in Bonheiden, Mechelen, Liège, and Leuven.
- Participants must be willing to visit the clinic weekly and follow a treatment schedule for 8 weeks.
- The study aims to see if the gel reduces wound size more effectively than usual treatments.
- If you have a diabetic foot ulcer, ask your doctor if this investigational gel might be a suitable option for you.
Read the full paper / source →
This content summarizes published medical research for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making treatment decisions.
Free consultation
Could this treatment help you?
Our DFU specialists review every inquiry personally. Tell us about your situation — response within 48 hours, no commitment required.
This website provides medical-information science popularization only. It does NOT provide online diagnosis, prescriptions, or medical advice. Consult a licensed physician for any medical decision.
Editor's note
This trial is testing a gel that is applied directly to the wound, which may create a better environment for healing. If you have a diabetic foot ulcer that hasn't healed with standard care, this approach could potentially reduce the risk of serious complications, like amputation, by accelerating wound closure. While similar advanced wound care products may not be widely available in all Chinese specialist DFU centers, some large hospitals and research institutions may offer them as part of clinical trials. If you are considering overseas treatment, be sure to discuss the costs, logistics, and potential benefits with your healthcare provider.